1. Home
  2. IPHA vs AVD Comparison

IPHA vs AVD Comparison

Compare IPHA & AVD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Innate Pharma S.A. ADS

IPHA

Innate Pharma S.A. ADS

HOLD

Current Price

$2.24

Market Cap

189.5M

Sector

Health Care

ML Signal

HOLD

Logo American Vanguard Corporation ($0.10 Par Value)

AVD

American Vanguard Corporation ($0.10 Par Value)

HOLD

Current Price

$2.88

Market Cap

58.8M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
IPHA
AVD
Founded
1999
1969
Country
France
United States
Employees
163
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Agricultural Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
189.5M
58.8M
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
IPHA
AVD
Price
$2.24
$2.88
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
1
Target Price
$5.75
$12.00
AVG Volume (30 Days)
126.4K
181.9K
Earning Date
03-26-2026
03-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
61.11
EPS
N/A
N/A
Revenue
N/A
$515,114,000.00
Revenue This Year
$180.36
$8.82
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.18
$2.05
52 Week High
$2.63
$5.92

Technical Indicators

Market Signals
Indicator
IPHA
AVD
Relative Strength Index (RSI) 65.66 50.81
Support Level $1.72 $2.65
Resistance Level $2.34 $5.47
Average True Range (ATR) 0.20 0.21
MACD 0.09 -0.00
Stochastic Oscillator 68.85 34.18

Price Performance

Historical Comparison
IPHA
AVD

About IPHA Innate Pharma S.A. ADS

Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. The company's approach includes therapeutic modalities such as monoclonal antibodies, multispecific NK cell engagers through its ANKET platform, and antibody-drug conjugates (ADC). Its portfolio includes lacutamab, which is being studied for cutaneous T-cell lymphomas and peripheral T-cell lymphomas, and monalizumab, which is being developed in collaboration with AstraZeneca for non-small cell lung cancer. The company's revenue mainly consists of revenues from collaboration and licensing agreements and government financing for research expenditure in the form of research tax credits, as well as other grants.

About AVD American Vanguard Corporation ($0.10 Par Value)

American Vanguard Corp is a United States-based diversified specialty and agricultural products company. The company is a manufacturer of specialty solutions that develops and markets safe synthetic, biological, and biorational products for agricultural, commercial, and consumer uses. These chemicals include insecticides, fungicides, herbicides, molluscicides, growth regulators, and soil fumigants, which are marketed in liquid, powder, and granular forms.

Share on Social Networks: